Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2012 Filed Nov 5, 2012 23:02 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 25,718 | $65.59 | $1,686,843.62 |
DisclosureSEC source: 0001179110-12-015703 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,346,926 Read SEC document |
| November 02, 2012 Filed Nov 5, 2012 23:02 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 100 | $65.59 | $6,558.90 |
DisclosureSEC source: 0001179110-12-015703 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,372,644 Read SEC document |
| November 02, 2012 Filed Nov 5, 2012 23:02 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 400 | $65.59 | $26,235.20 |
DisclosureSEC source: 0001179110-12-015703 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,372,744 Read SEC document |
| November 02, 2012 Filed Nov 5, 2012 23:02 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 6,200 | $65.59 | $406,627.00 |
DisclosureSEC source: 0001179110-12-015703 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,373,144 Read SEC document |
| November 01, 2012 Filed Nov 5, 2012 22:17 UTC |
Magill Paul KSenior Vice President
|
GrantCommon shares without par value | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-015694 · edgar.xml · nonDerivative · entry 1 Magill Paul K · CIK 0001561122 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| October 26, 2012 Filed Dec 14, 2012 22:49 UTC |
Landgraf John CExecutive Vice President
|
GiftCommon shares without par value | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-017666 · edgar.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,759 Read SEC document |
| October 25, 2012 Filed Oct 26, 2012 21:04 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 2,500 | $65.76 | $164,400.00 |
DisclosureSEC source: 0001179110-12-015434 · edgar.xml · nonDerivative · entry 2 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,724 Read SEC document |
| October 25, 2012 Filed Oct 26, 2012 21:04 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 1,500 | $65.76 | $98,641.50 |
DisclosureSEC source: 0001179110-12-015434 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,224 Read SEC document |
| October 24, 2012 Filed Oct 26, 2012 21:04 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,948 | $0.00 Strike: $60.39 | $0.00 |
DisclosureSEC source: 0001179110-12-015433 · edgar.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,948 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 24, 2012 Filed Oct 26, 2012 21:04 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 2,000 | $66.00 | $132,000.00 |
DisclosureSEC source: 0001179110-12-015433 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,093 Read SEC document |
| October 24, 2012 Filed Oct 26, 2012 21:04 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 5,948 | $66.00 | $392,568.00 |
DisclosureSEC source: 0001179110-12-015433 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,093 Read SEC document |
| October 24, 2012 Filed Oct 26, 2012 21:04 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,948 | $60.39 | $359,199.72 |
DisclosureSEC source: 0001179110-12-015433 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2012 Filed Oct 17, 2012 21:03 UTC |
ALBAN CARLOSSenior Vice President
|
Tax withholdingCommon shares without par value | 2,032 | $69.28 | $140,776.96 |
DisclosureSEC source: 0001179110-12-015251 · edgar.xml · nonDerivative · entry 2 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,685 Read SEC document |
| October 15, 2012 Filed Oct 17, 2012 21:03 UTC |
ALBAN CARLOSSenior Vice President
|
GrantCommon shares without par value | 4,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-015251 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,717 F1 · shares: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 30, 2012 Filed Oct 2, 2012 21:04 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 481 | $68.56 Strike: $0.00 | $32,977.36 |
DisclosureSEC source: 0001179110-12-014772 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,331 Underlying: Common shares · 481 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2012 Filed Oct 2, 2012 21:04 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 481 | $68.56 Strike: $0.00 | $32,977.36 |
DisclosureSEC source: 0001179110-12-014773 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,852 Underlying: Common shares · 481 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2012 Filed Oct 2, 2012 21:05 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 114 | $68.56 Strike: $0.00 | $7,815.84 |
DisclosureSEC source: 0001179110-12-014774 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,284 Underlying: Common shares · 114 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2012 Filed Oct 2, 2012 21:05 UTC |
OSBORN WILLIAM ADirector
|
GrantStock Equivalent Units · Derivative | 503 | $68.56 Strike: $0.00 | $34,485.68 |
DisclosureSEC source: 0001179110-12-014775 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,718 Underlying: Common shares · 503 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 25, 2012 Filed Sep 27, 2012 21:10 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,198 | $0.00 Strike: $57.25 | $0.00 |
DisclosureSEC source: 0001179110-12-014554 · edgar.xml · derivative · entry 3 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,198 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 25, 2012 Filed Sep 27, 2012 21:10 UTC |
ALBAN CARLOSSenior Vice President
|
SaleCommon shares without par value | 1,198 | $70.00 | $83,860.00 |
DisclosureSEC source: 0001179110-12-014554 · edgar.xml · nonDerivative · entry 2 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,817 Read SEC document |
| September 25, 2012 Filed Sep 27, 2012 21:10 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,198 | $57.25 | $68,585.50 |
DisclosureSEC source: 0001179110-12-014554 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 21, 2012 Filed Sep 25, 2012 21:05 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001179110-12-014492 · edgar.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common shares · 30,000 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 21, 2012 Filed Sep 25, 2012 21:05 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 23,538 | $69.86 | $1,644,364.68 |
DisclosureSEC source: 0001179110-12-014492 · edgar.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,548 Read SEC document |
| September 21, 2012 Filed Sep 25, 2012 21:05 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 30,000 | $44.16 | $1,324,800.00 |
DisclosureSEC source: 0001179110-12-014492 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2012 Filed Sep 21, 2012 21:09 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,918 | $0.00 Strike: $56.98 | $0.00 |
DisclosureSEC source: 0001179110-12-014369 · edgar.xml · derivative · entry 3 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,918 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 20, 2012 Filed Sep 21, 2012 21:09 UTC |
ALBAN CARLOSSenior Vice President
|
SaleCommon shares without par value | 1,918 | $69.75 | $133,780.50 |
DisclosureSEC source: 0001179110-12-014369 · edgar.xml · nonDerivative · entry 2 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,817 Read SEC document |
| September 20, 2012 Filed Sep 21, 2012 21:09 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,918 | $56.98 | $109,287.64 |
DisclosureSEC source: 0001179110-12-014369 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2012 Filed Sep 19, 2012 21:02 UTC |
Forrest A. DavidSenior Vice President
|
Tax withholdingCommon shares without par value | 954 | $68.27 | $65,129.58 |
DisclosureSEC source: 0001179110-12-014278 · edgar.xml · nonDerivative · entry 2 Forrest A. David · CIK 0001501589 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,015 Read SEC document |
| September 17, 2012 Filed Sep 19, 2012 21:02 UTC |
Forrest A. DavidSenior Vice President
|
GrantCommon shares without par value | 1,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-014278 · edgar.xml · nonDerivative · entry 1 Forrest A. David · CIK 0001501589 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,969 F1 · shares: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 14, 2012 Filed Sep 17, 2012 21:04 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 1,613 | $0.00 Strike: $69.27 | $0.00 |
DisclosureSEC source: 0001179110-12-014149 · edgar.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,613 Underlying: Common shares · 1,613 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 14, 2012 Filed Sep 17, 2012 21:04 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,839 | $0.00 Strike: $54.74 | $0.00 |
DisclosureSEC source: 0001179110-12-014149 · edgar.xml · derivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,839 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 14, 2012 Filed Sep 17, 2012 21:04 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon shares without par value | 1,613 | $69.27 | $111,732.51 |
DisclosureSEC source: 0001179110-12-014149 · edgar.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,289 Read SEC document |
| September 14, 2012 Filed Sep 17, 2012 21:04 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon shares without par value | 1,839 | $54.74 | $100,666.86 |
DisclosureSEC source: 0001179110-12-014149 · edgar.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2012 Filed Sep 17, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
GrantOption (right to buy) · Derivative | 2,923 | $0.00 Strike: $67.84 | $0.00 |
DisclosureSEC source: 0001179110-12-014150 · edgar.xml · derivative · entry 5 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,923 Underlying: Common shares · 2,923 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 13, 2012 Filed Sep 17, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,368 | $0.00 Strike: $54.05 | $0.00 |
DisclosureSEC source: 0001179110-12-014150 · edgar.xml · derivative · entry 4 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,368 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 13, 2012 Filed Sep 17, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
Tax withholdingCommon shares without par value | 2,923 | $67.84 | $198,296.32 |
DisclosureSEC source: 0001179110-12-014150 · edgar.xml · nonDerivative · entry 2 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,070 Read SEC document |
| September 13, 2012 Filed Sep 17, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,368 | $54.05 | $182,040.40 |
DisclosureSEC source: 0001179110-12-014150 · edgar.xml · nonDerivative · entry 1 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2012 Filed Sep 17, 2012 21:06 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,331 | $0.00 Strike: $56.00 | $0.00 |
DisclosureSEC source: 0001179110-12-014151 · edgar.xml · derivative · entry 3 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common shares · 1,331 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 (b) under Rule 16b-3. Read SEC document |
| September 13, 2012 Filed Sep 17, 2012 21:06 UTC |
ALBAN CARLOSSenior Vice President
|
SaleCommon shares without par value | 1,331 | $68.75 | $91,506.25 |
DisclosureSEC source: 0001179110-12-014151 · edgar.xml · nonDerivative · entry 2 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,817 Read SEC document |
| September 13, 2012 Filed Sep 17, 2012 21:06 UTC |
ALBAN CARLOSSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,331 | $56.00 | $74,536.00 |
DisclosureSEC source: 0001179110-12-014151 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2012 Filed Sep 11, 2012 21:13 UTC |
Landgraf John CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 21,972 | $0.00 Strike: $66.92 | $0.00 |
DisclosureSEC source: 0001179110-12-013903 · edgar.xml · derivative · entry 9 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,972 Underlying: Common shares · 21,972 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 07, 2012 Filed Sep 11, 2012 21:13 UTC |
Landgraf John CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 11,956 | $0.00 Strike: $66.92 | $0.00 |
DisclosureSEC source: 0001179110-12-013903 · edgar.xml · derivative · entry 8 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,956 Underlying: Common shares · 11,956 shares Expires 2014-08-02 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 07, 2012 Filed Sep 11, 2012 21:13 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 7,057 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001179110-12-013903 · edgar.xml · derivative · entry 7 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 7,057 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 07, 2012 Filed Sep 11, 2012 21:13 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 17,920 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001179110-12-013903 · edgar.xml · derivative · entry 6 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 17,920 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 07, 2012 Filed Sep 11, 2012 21:13 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 13,588 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001179110-12-013903 · edgar.xml · derivative · entry 5 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 13,588 shares Expires 2014-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 07, 2012 Filed Sep 11, 2012 21:13 UTC |
Landgraf John CExecutive Vice President
|
Tax withholdingCommon shares without par value | 33,928 | $66.92 | $2,270,461.76 |
DisclosureSEC source: 0001179110-12-013903 · edgar.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,849 Read SEC document |
| September 07, 2012 Filed Sep 11, 2012 21:13 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 7,057 | $53.12 | $374,867.84 |
DisclosureSEC source: 0001179110-12-013903 · edgar.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2012 Filed Sep 11, 2012 21:13 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 31,508 | $53.19 | $1,675,910.52 |
DisclosureSEC source: 0001179110-12-013903 · edgar.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2012 Filed Sep 5, 2012 21:16 UTC |
Landgraf John CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 6,247 | $0.00 Strike: $65.40 | $0.00 |
DisclosureSEC source: 0001179110-12-013703 · edgar.xml · derivative · entry 20 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,247 Underlying: Common shares · 6,247 shares Expires 2014-08-02 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 31, 2012 Filed Sep 5, 2012 21:16 UTC |
Landgraf John CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 7,156 | $0.00 Strike: $51.21 | $0.00 |
DisclosureSEC source: 0001179110-12-013703 · edgar.xml · derivative · entry 19 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 7,156 shares Expires 2014-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.